Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,655 total articles
NuCana plc, a clinical-stage biopharmaceutical company focused on cancer treatments, has appointed Ian Webster as Chief Financial Officer. Webster, formerly Interim CFO and Director of Finance, brings extensive financial and biopharmaceutical sector experience. His appointment comes as NuCana advances its Phase 2 clinical studies for NUC-7738 and N…
Nasus Pharma announces a virtual key opinion leader event on June 10, 2026, to present NS002, its intranasal epinephrine powder for anaphylaxis treatment, featuring expert discussion of Phase 2 data showing faster and higher absorption compared to EpiPen. The event aims to showcase NS002's potential as a needle-free alternative addressing unmet med…
Aprea Therapeutics presented updated Phase 1 clinical trial data for their oral WEE1 inhibitor, APR-1051, at ASCO 2026. The data demonstrated preliminary anti-tumor activity, including partial responses and stable disease in heavily pretreated patients with advanced solid tumors, along with a favorable safety and tolerability profile. Enrollment is…
Spectral AI, Inc. announced the results of its 2026 Annual Meeting confirming all shareholder proposals, including board elections and audit firm ratification. The company highlighted its receipt of FDA De Novo classification for the DeepView System, enabling commercial distribution in the U.S. It also secured $31.7 million funding from BARDA, expa…
BCB Bancorp, Inc., a New Jersey-based community bank holding company, has appointed Thomas M. O'Brien as President and Chief Executive Officer effective June 1, 2026. O'Brien brings extensive experience in community banking and aims to address recent operational and credit challenges faced by the company while focusing on regulatory compliance, cos…
Lyell Immunopharma announced that its senior management will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference in June 2026, highlighting its progress in developing next-generation CAR T-cell therapies for cancer, and revealing its commercial manufacturing capacity to support product launches.
ALX Oncology Holdings Inc., a clinical-stage biotech company focusing on novel cancer treatments, announced its participation in a fireside chat at the 2026 Jefferies Global Healthcare Conference. The company highlighted its lead candidate evorpacept, advancing through multiple clinical trials, and its second candidate ALX2004 currently in a Phase …
MAIA Biotechnology presented a Trial in Progress poster at the 2026 ASCO Annual Meeting detailing its pivotal Phase 3 clinical trial THIO-104, evaluating the efficacy of its novel telomere-targeting agent ateganosine in combination with checkpoint inhibitors for third-line treatment in non-small cell lung cancer patients resistant to current therap…
Outdoor Holding Company (Nasdaq: POWW), the owner of GunBroker.com, appointed Erich Buerger as Director of AI Strategy & Implementation to lead the company’s AI initiatives. This strategic hire aims to enhance marketplace functionality, operational efficiency, and long-term shareholder value through disciplined AI deployment aligned with the compan…
Kaltura has been named an Exemplary Provider in the ISG Research Buyers Guide on Conversational AI Emerging Providers. This accolade recognizes Kaltura's innovative conversational and agentic AI platform that enables personalized, real-time, context-aware digital engagement across multiple sectors. The company is expanding its AI capabilities throu…
Beyond Air, Inc. announced that the Nasdaq Hearings Panel has approved its request to continue listing on Nasdaq, provided the company regains compliance with the bid price requirement by July 31, 2026. The company plans to hold a shareholder vote on a reverse stock split to meet this requirement and remains focused on advancing its commercial and …
Agora, Inc., a leader in conversational AI and real-time engagement technology, announced that its CEO Tony Zhao intends to invest up to $20 million in the company’s shares over the next 12 months. This management share purchase plan aims to demonstrate confidence in the company's growth prospects amid expanding market opportunities in real-time en…
Immatics N.V. presented extended Phase 1b clinical trial data for its anzu-cel (IMA203) PRAME-targeted TCR T-cell therapy at the 2026 ASCO Annual Meeting, showing rapid, deep, and durable anti-tumor responses in heavily pretreated metastatic melanoma patients, including cutaneous and uveal subtypes. The therapy demonstrated a 56% confirmed overall …
Viasat Inc. has been selected by Lockheed Martin to supply high-bandwidth satellite communications technology for NOAA’s next-generation C-130J 'Hurricane Hunter' aircraft. This contract involves delivering Viasat's Hybrid SATCOM Approach technology to enable resilient, real-time data transmission supporting hurricane forecasting and severe weather…
zSpace, Inc., a provider of immersive augmented and virtual reality learning technology, announced it has converted more than $12 million of its outstanding debt into equity through agreements with lenders. This transaction eliminates related debt obligations, thus improving the company's financial foundation and enabling focus on its growth in edu…
Senseonics Holdings announced plans for an analyst event and an oral presentation at the upcoming ADA 2026 Scientific Sessions to showcase recent commercial milestones and new real-world evidence for their implantable Eversense 365 Continuous Glucose Monitoring system. These events will focus on the system's performance, integration with insulin pu…
OpenPayd has announced a definitive business combination with Titan Acquisition Corp. to become a publicly traded company on Nasdaq under the ticker OP. Valued at $1.145 billion on a pro-forma basis, OpenPayd operates a global financial infrastructure platform bridging traditional finance with digital assets, including stablecoins, via a single API…
Jasper Therapeutics, a clinical-stage biotech company focused on developing briquilimab for mast cell driven diseases, announced its Board of Directors will evaluate various strategic alternatives including asset sales, collaborations, merger, or wind-down, aiming to maximize shareholder value amid current market challenges. The company continues t…
Ten-League International Holdings Limited, a Singapore-based turnkey project solutions provider, announced it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share. Following a Nasdaq Hearings Panel review, the company was granted continued listing conditioned upon demonstrating compliance, which it has now achieved…
Vertex, Inc., a leader in enterprise compliance technology, will present at the 46th Annual William Blair Growth Stock Conference to discuss its AI-powered tax automation solutions that help global enterprises manage complex tax processes efficiently. The presentation aims to highlight the company's expertise and growth strategy in the compliance t…
STEALTHGAS INC., a ship-owning company serving the international liquefied petroleum gas (LPG) shipping sector, announced it will release its first quarter 2026 financial and operating results on June 5, 2026. The company will host a conference call and webcast to discuss the results and outlook.
NextCure presented promising Phase 1 dose escalation data for SIM0505, a novel anti-CDH6 antibody-drug conjugate targeting platinum-resistant ovarian cancer (PROC) and uterine serous carcinoma (USC). The study reported a 55% overall response rate in gynecologic cancers, with favorable safety and tolerability profiles. These results support ongoing …
Voyager Therapeutics announced FDA clearance of its Investigational New Drug (IND) application for VY1706, the company's gene therapy targeting tau protein to treat Alzheimer's disease (AD). This first-of-its-kind therapy uses an intravenous brain-targeted capsid to reduce tau production, with clinical dosing expected in the second half of 2026. Pr…
Amneal Pharmaceuticals, a diversified biopharmaceutical company specializing in affordable and innovative medicines, announced that Co-CEO Chirag Patel will present at the Goldman Sachs 47th Annual Global Healthcare Conference on June 9, 2026. The presentation will be webcast live and provide insights into the company's diverse portfolio and growth…
Elicio Therapeutics announced the publication of a peer-reviewed study in Science Advances detailing the potent immune responses generated by their novel AMP-DNA adjuvant platform. The preclinical research highlights superior efficacy, durable T cell activation, and a distinct lymph node-targeted mechanism, reinforcing the versatility and potential…
